Delphine Rolland

3.1k total citations · 1 hit paper
41 papers, 2.0k citations indexed

About

Delphine Rolland is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Delphine Rolland has authored 41 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Pathology and Forensic Medicine and 10 papers in Oncology. Recurrent topics in Delphine Rolland's work include Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Ubiquitin and proteasome pathways (4 papers). Delphine Rolland is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Ubiquitin and proteasome pathways (4 papers). Delphine Rolland collaborates with scholars based in United States, France and South Korea. Delphine Rolland's co-authors include Megan S. Lim, Kojo S.J. Elenitoba‐Johnson, Keith D. Wilner, Stephan D. Voss, Brenda J. Weigel, Peter C. Adamson, Susan M. Blaney, Yaël P. Mossé, Bryan L. Betz and Noah A. Brown and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Delphine Rolland

40 papers receiving 1.9k citations

Hit Papers

Safety and activity of crizotinib for paediatric patients... 2013 2026 2017 2021 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
    2013 477 citations Yaël P. Mossé, Megan S. Lim et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Delphine Rolland United States 17 700 677 598 349 299 41 2.0k
Ryo Ichinohasama Japan 26 716 1.0× 1.6k 2.4× 1.2k 2.0× 413 1.2× 488 1.6× 154 2.9k
Michaela Nathrath Germany 24 689 1.0× 313 0.5× 647 1.1× 110 0.3× 125 0.4× 70 1.8k
Gian Paolo Dagrada Italy 29 1.3k 1.8× 323 0.5× 1.1k 1.8× 145 0.4× 160 0.5× 78 2.8k
Natacha Entz‐Werlé France 19 588 0.8× 399 0.6× 428 0.7× 148 0.4× 218 0.7× 83 1.5k
Juan Luis Garcı́a Spain 29 1.3k 1.8× 806 1.2× 984 1.6× 110 0.3× 836 2.8× 127 3.2k
Susan Mathew United States 24 1.1k 1.6× 787 1.2× 785 1.3× 149 0.4× 548 1.8× 100 3.3k
Máirín E. McMenamin Ireland 17 705 1.0× 571 0.8× 404 0.7× 274 0.8× 40 0.1× 36 1.9k
Noah A. Brown United States 20 398 0.6× 350 0.5× 413 0.7× 57 0.2× 110 0.4× 60 1.5k
Lorenza Pecciarini Italy 17 836 1.2× 507 0.7× 860 1.4× 94 0.3× 219 0.7× 42 2.1k
Isidro Machado Spain 27 646 0.9× 417 0.6× 741 1.2× 153 0.4× 39 0.1× 126 2.2k

Countries citing papers authored by Delphine Rolland

Since Specialization
Citations

This map shows the geographic impact of Delphine Rolland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delphine Rolland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delphine Rolland more than expected).

Fields of papers citing papers by Delphine Rolland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delphine Rolland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delphine Rolland. The network helps show where Delphine Rolland may publish in the future.

Co-authorship network of co-authors of Delphine Rolland

This figure shows the co-authorship network connecting the top 25 collaborators of Delphine Rolland. A scholar is included among the top collaborators of Delphine Rolland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delphine Rolland. Delphine Rolland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poindron, Vincent, et al.. (2024). Evaluation of an integrated activated partial thromboplastin time (Cephen LS/Cephen) for the detection of lupus anticoagulant. International Journal of Laboratory Hematology. 46(6). 1109–1117. 1 indexed citations
2.
Rolland, Delphine, et al.. (2023). Factor V Leiden interferes with protein S activity assay. Research and Practice in Thrombosis and Haemostasis. 7(8). 102234–102234. 2 indexed citations
3.
Rolland, Delphine, Aude Lambert, Xavier Delabranche, et al.. (2023). Laboratory diagnosis of heparin‐induced thrombocytopenia: A retrospective experience. Journal of Clinical Laboratory Analysis. 37(7). e24884–e24884. 2 indexed citations
4.
Rolland, Delphine, Özlem Önder, Venkatesha Basrur, et al.. (2020). FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells. Cancer Research. 80(12). 2498–2511. 22 indexed citations
5.
Amin, Amit Dipak, Lingxiao Li, Delphine Rolland, et al.. (2019). The mechanism of cancer drug addiction in ALK-positive T-Cell lymphoma. Oncogene. 39(10). 2103–2117. 6 indexed citations
6.
Murga‐Zamalloa, Carlos, Delphine Rolland, Avery Polk, et al.. (2019). Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability. Clinical Cancer Research. 26(3). 690–703. 48 indexed citations
7.
Rolland, Delphine, Megan S. Lim, & Kojo S.J. Elenitoba‐Johnson. (2018). Mass spectrometry and proteomics in hematology. Seminars in Hematology. 56(1). 52–57. 11 indexed citations
8.
9.
Mossé, Yaël P., Stephan D. Voss, Megan S. Lim, et al.. (2017). Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study. Journal of Clinical Oncology. 35(28). 3215–3221. 247 indexed citations
10.
Udager, Aaron M., Delphine Rolland, Jonathan B. McHugh, et al.. (2015). High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma. Cancer Research. 75(13). 2600–2606. 97 indexed citations
11.
Kiel, Mark J., Anagh A. Sahasrabuddhe, Delphine Rolland, et al.. (2015). Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome. Nature Communications. 6(1). 8470–8470. 143 indexed citations
12.
Brown, Noah A., Delphine Rolland, Jonathan B. McHugh, et al.. (2014). Activating FGFR2–RAS–BRAF Mutations in Ameloblastoma. Clinical Cancer Research. 20(21). 5517–5526. 206 indexed citations
13.
14.
Mossé, Yaël P., Megan S. Lim, Stephan D. Voss, et al.. (2013). Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. The Lancet Oncology. 14(6). 472–480. 477 indexed citations breakdown →
15.
Guttin, Audrey, Michèle El Atifi, Claire Ramus, et al.. (2011). MicroRNA and Target Protein Patterns Reveal Physiopathological Features of Glioma Subtypes. PLoS ONE. 6(5). e20600–e20600. 116 indexed citations
16.
17.
Rolland, Delphine, et al.. (2010). Inhibition of GST-pi nuclear transfer increases mantle cell lymphoma sensitivity to cisplatin, cytarabine, gemcitabine, bortezomib and doxorubicin.. PubMed. 30(10). 3951–7. 17 indexed citations
18.
Rolland, Delphine, Vincent Ribrag, Corinne Haïoun, et al.. (2009). Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d’Etude des Lymphomes de l’Adulte trial. Cancer Chemotherapy and Pharmacology. 65(4). 781–790. 15 indexed citations
19.
Rolland, Delphine, Valérie Camara‐Clayette, Gilles Salles, et al.. (2007). Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma. Cancer Chemotherapy and Pharmacology. 61(5). 855–863. 18 indexed citations
20.
Rolland, Delphine, et al.. (2000). The analysis of basic and acidic compounds using non-aqueous CE and non-aqueous CE-MS. Journal of Pharmaceutical and Biomedical Analysis. 22(3). 413–421. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryo Ichinohasama Breakdown of academic impact, for papers by Michaela Nathrath Breakdown of academic impact, for papers by Gian Paolo Dagrada Breakdown of academic impact, for papers by Natacha Entz‐Werlé Breakdown of academic impact, for papers by Juan Luis Garcı́a Breakdown of academic impact, for papers by Susan Mathew Breakdown of academic impact, for papers by Máirín E. McMenamin Breakdown of academic impact, for papers by Noah A. Brown Breakdown of academic impact, for papers by Lorenza Pecciarini Breakdown of academic impact, for papers by Isidro Machado
Rankless by CCL
2026